ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 118 filers reported holding ANI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,545,931 | +23.8% | 43,850 | +14.8% | 0.00% | 0.0% |
| Q2 2023 | $2,056,520 | +76.6% | 38,204 | +30.3% | 0.00% | – |
| Q1 2023 | $1,164,671 | -2.7% | 29,322 | -1.4% | 0.00% | – |
| Q4 2022 | $1,196,762 | +29.7% | 29,748 | +3.6% | 0.00% | – |
| Q3 2022 | $923,000 | +2.9% | 28,727 | -5.0% | 0.00% | – |
| Q2 2022 | $897,000 | +8.3% | 30,248 | +2.7% | 0.00% | – |
| Q1 2022 | $828,000 | -31.8% | 29,446 | +11.8% | 0.00% | – |
| Q4 2021 | $1,214,000 | +68.4% | 26,340 | +19.9% | 0.00% | – |
| Q3 2021 | $721,000 | +0.7% | 21,964 | +7.3% | 0.00% | – |
| Q2 2021 | $716,000 | -25.6% | 20,468 | -23.1% | 0.00% | – |
| Q1 2021 | $963,000 | +26.0% | 26,609 | +1.1% | 0.00% | – |
| Q4 2020 | $764,000 | +2.4% | 26,325 | -0.5% | 0.00% | – |
| Q3 2020 | $746,000 | -10.6% | 26,459 | +2.6% | 0.00% | – |
| Q2 2020 | $834,000 | -13.2% | 25,786 | +9.2% | 0.00% | -100.0% |
| Q1 2020 | $961,000 | -34.1% | 23,609 | -0.2% | 0.00% | 0.0% |
| Q4 2019 | $1,458,000 | -8.5% | 23,645 | +8.2% | 0.00% | 0.0% |
| Q3 2019 | $1,593,000 | -2.5% | 21,855 | +9.9% | 0.00% | 0.0% |
| Q2 2019 | $1,634,000 | +18.5% | 19,883 | +1.7% | 0.00% | 0.0% |
| Q1 2019 | $1,379,000 | +75.9% | 19,549 | +11.3% | 0.00% | 0.0% |
| Q4 2018 | $784,000 | -21.4% | 17,565 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $998,000 | -16.7% | 17,712 | -0.9% | 0.00% | 0.0% |
| Q2 2018 | $1,198,000 | +24.4% | 17,876 | +8.0% | 0.00% | 0.0% |
| Q1 2018 | $963,000 | -7.3% | 16,558 | +2.6% | 0.00% | 0.0% |
| Q4 2017 | $1,039,000 | +22.7% | 16,141 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $847,000 | +24.0% | 16,141 | +10.7% | 0.00% | 0.0% |
| Q2 2017 | $683,000 | +6.4% | 14,581 | +12.5% | 0.00% | 0.0% |
| Q1 2017 | $642,000 | -18.5% | 12,963 | -0.3% | 0.00% | 0.0% |
| Q4 2016 | $788,000 | +79.9% | 12,996 | +96.8% | 0.00% | – |
| Q3 2016 | $438,000 | +618.0% | 6,602 | +506.2% | 0.00% | – |
| Q2 2016 | $61,000 | +69.4% | 1,089 | 0.0% | 0.00% | – |
| Q1 2016 | $36,000 | -29.4% | 1,089 | 0.0% | 0.00% | – |
| Q4 2015 | $51,000 | +24.4% | 1,089 | 0.0% | 0.00% | – |
| Q3 2015 | $41,000 | -38.8% | 1,089 | 0.0% | 0.00% | – |
| Q2 2015 | $67,000 | -1.5% | 1,089 | 0.0% | 0.00% | – |
| Q1 2015 | $68,000 | +325.0% | 1,089 | +280.8% | 0.00% | – |
| Q4 2014 | $16,000 | – | 286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |